Skip to content

Clinical trials

Phase 3 Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 3 Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20023
20051
20093
20102
20133
20171
20191
20202
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting6
Terminated5
Not yet recruiting2
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology6
National Cancer Institute (NCI)5
Fudan University4
Novartis Pharmaceuticals2
Radiation Therapy Oncology Group2
SWOG Cancer Research Network2
Celltrion1
ECOG-ACRIN Cancer Research Group1
Eastern Cooperative Oncology Group1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung39
Carcinoma, Non-Small-Cell Lung29
Lung Neoplasms23
Adenocarcinoma, Bronchiolo-Alveolar12
Brain Neoplasms1
Fatigue1
Lymphatic Metastasis1
Nausea1
Pain1
Vomiting1

Trials

Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.